128 related articles for article (PubMed ID: 36896423)
1. Protein domains provide a new layer of information for classifying human variations in rare diseases.
Corcuff M; Garibal M; Desvignes JP; Guien C; Grattepanche C; Collod-Béroud G; Ménoret E; Salgado D; Béroud C
Front Bioinform; 2023; 3():1127341. PubMed ID: 36896423
[No Abstract] [Full Text] [Related]
2. Enhancing rare variant interpretation in inherited arrhythmias through quantitative analysis of consortium disease cohorts and population controls.
Walsh R; Lahrouchi N; Tadros R; Kyndt F; Glinge C; Postema PG; Amin AS; Nannenberg EA; Ware JS; Whiffin N; Mazzarotto F; Škorić-Milosavljević D; Krijger C; Arbelo E; Babuty D; Barajas-Martinez H; Beckmann BM; Bézieau S; Bos JM; Breckpot J; Campuzano O; Castelletti S; Celen C; Clauss S; Corveleyn A; Crotti L; Dagradi F; de Asmundis C; Denjoy I; Dittmann S; Ellinor PT; Ortuño CG; Giustetto C; Gourraud JB; Hazeki D; Horie M; Ishikawa T; Itoh H; Kaneko Y; Kanters JK; Kimoto H; Kotta MC; Krapels IPC; Kurabayashi M; Lazarte J; Leenhardt A; Loeys BL; Lundin C; Makiyama T; Mansourati J; Martins RP; Mazzanti A; Mörner S; Napolitano C; Ohkubo K; Papadakis M; Rudic B; Molina MS; Sacher F; Sahin H; Sarquella-Brugada G; Sebastiano R; Sharma S; Sheppard MN; Shimamoto K; Shoemaker MB; Stallmeyer B; Steinfurt J; Tanaka Y; Tester DJ; Usuda K; van der Zwaag PA; Van Dooren S; Van Laer L; Winbo A; Winkel BG; Yamagata K; Zumhagen S; Volders PGA; Lubitz SA; Antzelevitch C; Platonov PG; Odening KE; Roden DM; Roberts JD; Skinner JR; Tfelt-Hansen J; van den Berg MP; Olesen MS; Lambiase PD; Borggrefe M; Hayashi K; Rydberg A; Nakajima T; Yoshinaga M; Saenen JB; Kääb S; Brugada P; Robyns T; Giachino DF; Ackerman MJ; Brugada R; Brugada J; Gimeno JR; Hasdemir C; Guicheney P; Priori SG; Schulze-Bahr E; Makita N; Schwartz PJ; Shimizu W; Aiba T; Schott JJ; Redon R; Ohno S; Probst V; ; Behr ER; Barc J; Bezzina CR
Genet Med; 2021 Jan; 23(1):47-58. PubMed ID: 32893267
[TBL] [Abstract][Full Text] [Related]
3. Evaluating the use of paralogous protein domains to increase data availability for missense variant classification.
Gunning AC; Wright CF
Genome Med; 2023 Dec; 15(1):110. PubMed ID: 38087376
[TBL] [Abstract][Full Text] [Related]
4. Variability in gene-based knowledge impacts variant classification: an analysis of FBN1 missense variants in ClinVar.
Baudhuin LM; Kluge ML; Kotzer KE; Lagerstedt SA
Eur J Hum Genet; 2019 Oct; 27(10):1550-1560. PubMed ID: 31227806
[TBL] [Abstract][Full Text] [Related]
5. VIP-HL: Semi-automated ACMG/AMP variant interpretation platform for genetic hearing loss.
Peng J; Xiang J; Jin X; Meng J; Song N; Chen L; Abou Tayoun A; Peng Z
Hum Mutat; 2021 Dec; 42(12):1567-1575. PubMed ID: 34428318
[TBL] [Abstract][Full Text] [Related]
6. DNA variant classification-reconsidering "allele rarity" and "phenotype" criteria in ACMG/AMP guidelines.
Davieson CD; Joyce KE; Sharma L; Shovlin CL
Eur J Med Genet; 2021 Oct; 64(10):104312. PubMed ID: 34411772
[TBL] [Abstract][Full Text] [Related]
7. Systematic misclassification of missense variants in BRCA1 and BRCA2 "coldspots".
Dines JN; Shirts BH; Slavin TP; Walsh T; King MC; Fowler DM; Pritchard CC
Genet Med; 2020 May; 22(5):825-830. PubMed ID: 31911673
[TBL] [Abstract][Full Text] [Related]
8. Expanding ACMG variant classification guidelines into a general framework.
Masson E; Zou WB; Génin E; Cooper DN; Le Gac G; Fichou Y; Pu N; Rebours V; Férec C; Liao Z; Chen JM
Hum Genomics; 2022 Aug; 16(1):31. PubMed ID: 35974416
[TBL] [Abstract][Full Text] [Related]
9. Disease-specific ACMG/AMP guidelines improve sequence variant interpretation for hearing loss.
Patel MJ; DiStefano MT; Oza AM; Hughes MY; Wilcox EH; Hemphill SE; Cushman BJ; Grant AR; Siegert RK; Shen J; Chapin A; Boczek NJ; Schimmenti LA; Nara K; Kenna M; Azaiez H; Booth KT; Avraham KB; Kremer H; Griffith AJ; Rehm HL; Amr SS; Tayoun ANA;
Genet Med; 2021 Nov; 23(11):2208-2212. PubMed ID: 34230634
[TBL] [Abstract][Full Text] [Related]
10. Adapting ACMG/AMP sequence variant classification guidelines for single-gene copy number variants.
Brandt T; Sack LM; Arjona D; Tan D; Mei H; Cui H; Gao H; Bean LJH; Ankala A; Del Gaudio D; Knight Johnson A; Vincent LM; Reavey C; Lai A; Richard G; Meck JM
Genet Med; 2020 Feb; 22(2):336-344. PubMed ID: 31534211
[TBL] [Abstract][Full Text] [Related]
11. Differential Domain Distribution of gnomAD- and Disease-Linked Connexin Missense Variants.
Bai D; Wang J; Li T; Chan R; Atalla M; Chen RC; Khazaneh MT; An RJ; Stathopulos PB
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360596
[TBL] [Abstract][Full Text] [Related]
12. Refinement of the clinical variant interpretation framework by statistical evidence and machine learning.
Takata A; Hamanaka K; Matsumoto N
Med; 2021 May; 2(5):611-632.e9. PubMed ID: 35590234
[TBL] [Abstract][Full Text] [Related]
13. Variant curation expert panel recommendations for RYR1 pathogenicity classifications in malignant hyperthermia susceptibility.
Johnston JJ; Dirksen RT; Girard T; Gonsalves SG; Hopkins PM; Riazi S; Saddic LA; Sambuughin N; Saxena R; Stowell K; Weber J; Rosenberg H; Biesecker LG
Genet Med; 2021 Jul; 23(7):1288-1295. PubMed ID: 33767344
[TBL] [Abstract][Full Text] [Related]
14. Recommendations for interpreting the loss of function PVS1 ACMG/AMP variant criterion.
Abou Tayoun AN; Pesaran T; DiStefano MT; Oza A; Rehm HL; Biesecker LG; Harrison SM;
Hum Mutat; 2018 Nov; 39(11):1517-1524. PubMed ID: 30192042
[TBL] [Abstract][Full Text] [Related]
15. The landscape of regional missense mutational intolerance quantified from 125,748 exomes.
Chao KR; Wang L; Panchal R; Liao C; Abderrazzaq H; Ye R; Schultz P; Compitello J; Grant RH; Kosmicki JA; Weisburd B; Phu W; Wilson MW; Laricchia KM; Goodrich JK; Goldstein D; Goldstein JI; Vittal C; Poterba T; Baxter S; Watts NA; Solomonson M; ; Tiao G; Rehm HL; Neale BM; Talkowski ME; MacArthur DG; O'Donnell-Luria A; Karczewski KJ; Radivojac P; Daly MJ; Samocha KE
bioRxiv; 2024 May; ():. PubMed ID: 38645134
[TBL] [Abstract][Full Text] [Related]
16. Spectrum of DDC variants causing aromatic l-amino acid decarboxylase (AADC) deficiency and pathogenicity interpretation using ACMG-AMP/ACGS recommendations.
Himmelreich N; Montioli R; Garbade SF; Kopesky J; Elsea SH; Carducci C; Voltattorni CB; Blau N
Mol Genet Metab; 2022 Dec; 137(4):359-381. PubMed ID: 36427457
[TBL] [Abstract][Full Text] [Related]
17. Application of ACMG criteria to classify variants in the human gene mutation database.
Qu HQ; Wang X; Tian L; Hakonarson H
J Hum Genet; 2019 Nov; 64(11):1091-1095. PubMed ID: 31451714
[TBL] [Abstract][Full Text] [Related]
18. Good performance of the criteria of American College of Medical Genetics and Genomics/Association for Molecular Pathology in prediction of pathogenicity of genetic variants causing thoracic aortic aneurysms and dissections.
Ponińska JK; Bilińska ZT; Truszkowska G; Michalak E; Podgórska A; Stępień-Wojno M; Chmielewski P; Lutyńska A; Płoski R
J Transl Med; 2022 Jan; 20(1):42. PubMed ID: 35078481
[TBL] [Abstract][Full Text] [Related]
19. Proposition of adjustments to the ACMG-AMP framework for the interpretation of MEN1 missense variants.
Romanet P; Odou MF; North MO; Saveanu A; Coppin L; Pasmant E; Mohamed A; Goudet P; Borson-Chazot F; Calender A; Béroud C; Lévy N; Giraud S; Barlier A
Hum Mutat; 2019 Jun; 40(6):661-674. PubMed ID: 30869828
[TBL] [Abstract][Full Text] [Related]
20. Estimating the proportion of pathogenic variants from breast cancer case-control data: Application to calibration of ACMG/AMP variant classification criteria.
James PA; Fortuno C; Li N; Lim BWX; Campbell IG; Spurdle AB
Hum Mutat; 2022 Jul; 43(7):882-888. PubMed ID: 35191126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
